# Post-authorisation Passive Enhanced Safety Surveillance of Seasonal Influenza Vaccines

> **NCT02893878** · — · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 19334 (actual)

## Conditions studied

- Influenza, Human

## Interventions

- **OTHER:** Vaccine safety surveillance

## Key facts

- **NCT ID:** NCT02893878
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-09-12
- **Primary completion:** 2016-11-24
- **Final completion:** 2016-11-24
- **Target enrollment:** 19334 (ACTUAL)
- **Last updated:** 2019-02-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02893878

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02893878, "Post-authorisation Passive Enhanced Safety Surveillance of Seasonal Influenza Vaccines". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT02893878. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*